These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 28456768

  • 1. Corticotropin releasing factor receptor 1 antagonist differentially inhibits freezing behavior and changes gamma-aminobutyric acidergic activity in the amygdala in low- and high-anxiety rats.
    Skorzewska A, Wislowska-Stanek A, Lehner M, Turzynska D, Sobolewska A, Krzascik P, Plaznik A.
    J Physiol Pharmacol; 2017 Feb; 68(1):35-46. PubMed ID: 28456768
    [Abstract] [Full Text] [Related]

  • 2. The effect of a corticotropin-releasing factor receptor 1 antagonist on the fear conditioning response in low- and high-anxiety rats after chronic corticosterone administration.
    Skórzewska A, Wisłowska-Stanek A, Lehner M, Turzyńska D, Sobolewska A, Krząścik P, Szyndler J, Maciejak P, Płaźnik A.
    Stress; 2019 Jan; 22(1):113-122. PubMed ID: 30345859
    [Abstract] [Full Text] [Related]

  • 3. Midazolam treatment before re-exposure to contextual fear reduces freezing behavior and amygdala activity differentially in high- and low-anxiety rats.
    Skórzewska A, Lehner M, Wisłowska-Stanek A, Turzyńska D, Sobolewska A, Krząścik P, Płaźnik A.
    Pharmacol Biochem Behav; 2015 Feb; 129():34-44. PubMed ID: 25482326
    [Abstract] [Full Text] [Related]

  • 4. The effects of midazolam and D-cycloserine on the release of glutamate and GABA in the basolateral amygdala of low and high anxiety rats during extinction trial of a conditioned fear test.
    Lehner M, Wisłowska-Stanek A, Taracha E, Maciejak P, Szyndler J, Skórzewska A, Turzyńska D, Sobolewska A, Hamed A, Bidziński A, Płaźnik A.
    Neurobiol Learn Mem; 2010 Nov; 94(4):468-80. PubMed ID: 20807585
    [Abstract] [Full Text] [Related]

  • 5. The role of the dorsomedial part of the prefrontal cortex serotonergic innervation in rat responses to the aversively conditioned context: behavioral, biochemical and immunocytochemical studies.
    Lehner M, Taracha E, Turzyńska D, Sobolewska A, Hamed A, Kołomańska P, Skórzewska A, Maciejak P, Szyndler J, Bidziński A, Płaźnik A.
    Behav Brain Res; 2008 Oct 10; 192(2):203-15. PubMed ID: 18499280
    [Abstract] [Full Text] [Related]

  • 6. GABAergic control of the activity of the central nucleus of the amygdala in low- and high-anxiety rats.
    Skórzewska A, Lehner M, Wisłowska-Stanek A, Turzyńska D, Sobolewska A, Krząścik P, Płaźnik A.
    Neuropharmacology; 2015 Dec 10; 99():566-76. PubMed ID: 26318100
    [Abstract] [Full Text] [Related]

  • 7. The effect of CRF and alpha-helical CRF((9-41)) on rat fear responses and amino acids release in the central nucleus of the amygdala.
    Skórzewska A, Bidziński A, Hamed A, Lehner M, Turzyńska D, Sobolewska A, Szyndler J, Maciejak P, Wisłowska-Stanek A, Płaźnik A.
    Neuropharmacology; 2009 Aug 10; 57(2):148-56. PubMed ID: 19477189
    [Abstract] [Full Text] [Related]

  • 8. Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats.
    Cippitelli A, Ayanwuyi LO, Barbier E, Domi E, Lerma-Cabrera JM, Carvajal F, Scuppa G, Li H, Ubaldi M, Heilig M, Roberto M, Ciccocioppo R.
    Psychopharmacology (Berl); 2015 Mar 10; 232(6):1083-93. PubMed ID: 25260340
    [Abstract] [Full Text] [Related]

  • 9. Antagonizing corticotropin-releasing factor in the central nucleus of the amygdala attenuates fear-induced reductions in sleep but not freezing.
    Liu X, Wellman LL, Yang L, Ambrozewicz MA, Tang X, Sanford LD.
    Sleep; 2011 Nov 01; 34(11):1539-49. PubMed ID: 22043125
    [Abstract] [Full Text] [Related]

  • 10. Differences in the density of GABA-A receptor alpha-2 subunits and gephyrin in brain structures of rats selected for low and high anxiety in basal and fear-stimulated conditions, in a model of contextual fear conditioning.
    Lehner M, Wisłowska-Stanek A, Skórzewska A, Maciejak P, Szyndler J, Turzyńska D, Sobolewska A, Płaźnik A.
    Neurobiol Learn Mem; 2010 Nov 01; 94(4):499-508. PubMed ID: 20833253
    [Abstract] [Full Text] [Related]

  • 11. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY, van Leeuwen ML, Westphal KG, Olivier B, Groenink L.
    Neuroscience; 2011 Jan 26; 173():82-92. PubMed ID: 21093544
    [Abstract] [Full Text] [Related]

  • 12. Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear.
    Hubbard DT, Nakashima BR, Lee I, Takahashi LK.
    Neuroscience; 2007 Dec 19; 150(4):818-28. PubMed ID: 17988803
    [Abstract] [Full Text] [Related]

  • 13. The effect of chronic administration of corticosterone on anxiety- and depression-like behavior and the expression of GABA-A receptor alpha-2 subunits in brain structures of low- and high-anxiety rats.
    Skórzewska A, Lehner M, Wisłowska-Stanek A, Krząścik P, Ziemba A, Płaźnik A.
    Horm Behav; 2014 Jan 19; 65(1):6-13. PubMed ID: 24200620
    [Abstract] [Full Text] [Related]

  • 14. Early life stress is a risk factor for excessive alcohol drinking and impulsivity in adults and is mediated via a CRF/GABA(A) mechanism.
    Gondré-Lewis MC, Warnock KT, Wang H, June HL, Bell KA, Rabe H, Tiruveedhula VV, Cook J, Lüddens H, Aurelian L, June HL.
    Stress; 2016 Jan 19; 19(2):235-47. PubMed ID: 27023221
    [Abstract] [Full Text] [Related]

  • 15. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.
    Deak T, Nguyen KT, Ehrlich AL, Watkins LR, Spencer RL, Maier SF, Licinio J, Wong ML, Chrousos GP, Webster E, Gold PW.
    Endocrinology; 1999 Jan 19; 140(1):79-86. PubMed ID: 9886810
    [Abstract] [Full Text] [Related]

  • 16. Similar effect of CRF1 and CRF2 receptor in the basolateral or central nuclei of the amygdala on tonic immobility behavior.
    Spinieli RL, Leite-Panissi CRA.
    Brain Res Bull; 2018 Mar 19; 137():187-196. PubMed ID: 29246866
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vivo knockdown of GAD67 in the amygdala disrupts fear extinction and the anxiolytic-like effect of diazepam in mice.
    Heldt SA, Mou L, Ressler KJ.
    Transl Psychiatry; 2012 Nov 13; 2(11):e181. PubMed ID: 23149445
    [Abstract] [Full Text] [Related]

  • 19. The expression of c-Fos and colocalisation of c-Fos and glucocorticoid receptors in brain structures of low and high anxiety rats subjected to extinction trials and re-learning of a conditioned fear response.
    Lehner M, Wisłowska-Stanek A, Taracha E, Maciejak P, Szyndler J, Skórzewska A, Turzyńska D, Sobolewska A, Hamed A, Bidziński A, Płaźnik A.
    Neurobiol Learn Mem; 2009 Nov 13; 92(4):535-43. PubMed ID: 19596457
    [Abstract] [Full Text] [Related]

  • 20. CRF type 1 receptors of the medial amygdala modulate inhibitory avoidance responses in the elevated T-maze.
    Vicentini JE, Céspedes IC, Nascimento JO, Bittencourt JC, Viana MB.
    Horm Behav; 2014 Mar 13; 65(3):195-202. PubMed ID: 24472740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.